120 related articles for article (PubMed ID: 37619557)
1. Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-
Hayton C; Ahmed W; Cunningham P; Piper-Hanley K; Pearmain L; Chaudhuri N; Leonard C; Blaikley JF; Fowler SJ
J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37619557
[TBL] [Abstract][Full Text] [Related]
2. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
3. Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath.
Taylor MJ; Chitwood CP; Xie Z; Miller HA; van Berkel VH; Fu XA; Frieboes HB; Suliman SA
Respir Med; 2024 Feb; 222():107534. PubMed ID: 38244700
[TBL] [Abstract][Full Text] [Related]
4. Volatile metabolites differentiate air-liquid interface cultures after infection with
Ahmed W; Bardin E; Davis MD; Sermet-Gaudelus I; Grassin Delyle S; Fowler SJ
Analyst; 2023 Jan; 148(3):618-627. PubMed ID: 36597770
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β
Togami K; Yamaguchi K; Chono S; Tada H
J Pharmacol Toxicol Methods; 2017 Jul; 86():19-27. PubMed ID: 28259823
[TBL] [Abstract][Full Text] [Related]
6. The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice.
Guan S; Liu H; Zhou J; Zhang Q; Bi H
Toxicol Lett; 2022 Jun; 363():45-54. PubMed ID: 35472619
[TBL] [Abstract][Full Text] [Related]
7. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
8. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
9. Collagen 3D matrices as a model for the study of cell behavior in pulmonary fibrosis.
Machahua C; Vicens-Zygmunt V; Ríos-Martín J; Llatjós R; Escobar-Campuzano I; Molina-Molina M; Montes-Worboys A
Exp Lung Res; 2022 Apr; 48(3):126-136. PubMed ID: 35594338
[No Abstract] [Full Text] [Related]
10. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
11. Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry.
Gerritsen MG; Brinkman P; Escobar N; Bos LD; de Heer K; Meijer M; Janssen HG; de Cock H; Wösten HAB; Visser CE; van Oers MHJ; Sterk PJ
Med Mycol; 2018 Feb; 56(2):253-256. PubMed ID: 28525576
[TBL] [Abstract][Full Text] [Related]
12. MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway.
Ballester B; Milara J; Montero P; Cortijo J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204432
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
[TBL] [Abstract][Full Text] [Related]
14. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β
Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489
[TBL] [Abstract][Full Text] [Related]
15. Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures.
Baranska A; Smolinska A; Boots AW; Dallinga JW; van Schooten FJ
J Breath Res; 2015 Oct; 9(4):047102. PubMed ID: 26469548
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
17. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W
Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803
[TBL] [Abstract][Full Text] [Related]
18. Volatile organic compound signature from co-culture of lung epithelial cell line with Pseudomonas aeruginosa.
Lawal O; Knobel H; Weda H; Bos LD; Nijsen TME; Goodacre R; Fowler SJ
Analyst; 2018 Jul; 143(13):3148-3155. PubMed ID: 29878008
[TBL] [Abstract][Full Text] [Related]
19. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
[TBL] [Abstract][Full Text] [Related]
20. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
